409 related articles for article (PubMed ID: 16517404)
1. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents.
Overton HA; Babbs AJ; Doel SM; Fyfe MC; Gardner LS; Griffin G; Jackson HC; Procter MJ; Rasamison CM; Tang-Christensen M; Widdowson PS; Williams GM; Reynet C
Cell Metab; 2006 Mar; 3(3):167-75. PubMed ID: 16517404
[TBL] [Abstract][Full Text] [Related]
2. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis.
Lan H; Vassileva G; Corona A; Liu L; Baker H; Golovko A; Abbondanzo SJ; Hu W; Yang S; Ning Y; Del Vecchio RA; Poulet F; Laverty M; Gustafson EL; Hedrick JA; Kowalski TJ
J Endocrinol; 2009 May; 201(2):219-30. PubMed ID: 19282326
[TBL] [Abstract][Full Text] [Related]
3. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
[TBL] [Abstract][Full Text] [Related]
4. Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice.
Thabuis C; Destaillats F; Landrier JF; Tissot-Favre D; Martin JC
J Nutr Biochem; 2010 Oct; 21(10):922-8. PubMed ID: 19954948
[TBL] [Abstract][Full Text] [Related]
5. Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration.
Oveisi F; Gaetani S; Eng KT; Piomelli D
Pharmacol Res; 2004 May; 49(5):461-6. PubMed ID: 14998556
[TBL] [Abstract][Full Text] [Related]
6. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.
Lauffer LM; Iakoubov R; Brubaker PL
Diabetes; 2009 May; 58(5):1058-66. PubMed ID: 19208912
[TBL] [Abstract][Full Text] [Related]
7. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.
Suardíaz M; Estivill-Torrús G; Goicoechea C; Bilbao A; Rodríguez de Fonseca F
Pain; 2007 Dec; 133(1-3):99-110. PubMed ID: 17449181
[TBL] [Abstract][Full Text] [Related]
8. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA
Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties.
Astarita G; Di Giacomo B; Gaetani S; Oveisi F; Compton TR; Rivara S; Tarzia G; Mor M; Piomelli D
J Pharmacol Exp Ther; 2006 Aug; 318(2):563-70. PubMed ID: 16702440
[TBL] [Abstract][Full Text] [Related]
10. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
[TBL] [Abstract][Full Text] [Related]
11. Role of endocannabinoids and their analogues in obesity and eating disorders.
Gaetani S; Kaye WH; Cuomo V; Piomelli D
Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
[TBL] [Abstract][Full Text] [Related]
12. The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.
Stone VM; Dhayal S; Smith DM; Lenaghan C; Brocklehurst KJ; Morgan NG
Br J Pharmacol; 2012 Apr; 165(8):2758-70. PubMed ID: 22029844
[TBL] [Abstract][Full Text] [Related]
13. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
[TBL] [Abstract][Full Text] [Related]
14. GPR119 as a fat sensor.
Hansen HS; Rosenkilde MM; Holst JJ; Schwartz TW
Trends Pharmacol Sci; 2012 Jul; 33(7):374-81. PubMed ID: 22560300
[TBL] [Abstract][Full Text] [Related]
15. Stimulating beta cell replication and improving islet graft function by GPR119 agonists.
Gao J; Tian L; Weng G; Bhagroo NV; Sorenson RL; O'Brien TD; Luo J; Guo Z
Transpl Int; 2011 Nov; 24(11):1124-34. PubMed ID: 21902730
[TBL] [Abstract][Full Text] [Related]
16. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119.
Nieto A; Fernández-Vega V; Spicer TP; Sturchler E; Adhikari P; Kennedy N; Mandat S; Chase P; Scampavia L; Bannister T; Hodder P; McDonald PH
Assay Drug Dev Technol; 2018 Jul; 16(5):278-288. PubMed ID: 30019946
[TBL] [Abstract][Full Text] [Related]
18. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119.
Hassing HA; Fares S; Larsen O; Pad H; Hauge M; Jones RM; Schwartz TW; Hansen HS; Rosenkilde MM
Biochem Pharmacol; 2016 Nov; 119():66-75. PubMed ID: 27569424
[TBL] [Abstract][Full Text] [Related]
19. Regulation of GPR119 receptor activity with endocannabinoid-like lipids.
Syed SK; Bui HH; Beavers LS; Farb TB; Ficorilli J; Chesterfield AK; Kuo MS; Bokvist K; Barrett DG; Efanov AM
Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1469-78. PubMed ID: 23074242
[TBL] [Abstract][Full Text] [Related]
20. A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula.
Kang Y; Sato H; Saito M; Yin DX; Park SK; Oh SB; Bae YC; Toyoda H
Sci Rep; 2016 Sep; 6():32529. PubMed ID: 27581068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
